Attributable Mortality of Nosocomial Candidemia, Revisited
The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These infections are associated with attributable mortality rates that have ranged from 38% between 1983 and 1986 (46) to 49% in the same institutions between 1997 and 2001 (13).”
In the citing paper
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in controls; the resulting ''attributable mortality'' was therefore estimated to be 49%.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [12]
In the citing paper
“Studies on patients with IC have similarly shown excessive rates of inappropriate initial therapy and even higher mortality than infections caused by bacterial pathogens in the ICU setting.10,14,33,34,[42][43][44][45][46][47]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
In the citing paper
“Numerous reports have documented the association between inadequate dosing of antifungals in patients with IC and increased length of hospital stay, health care costs, morbidity, and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Research works printed but not linked: 3
- Harvey, 1987, Archives of Internal Medicine, 147, 2117, 10.1001/archinte.1987.00370120053011 · doi:10.1001/archinte.1987.00370120053011
- Martin, 1989, Annals of Internal Medicine, 110, 9, 10.1059/0003-4819-110-1-9 · doi:10.1059/0003-4819-110-1-9
- O'Grady, 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 51, 1
Cited by
Items 501–600 of 1,000
Invasive candidiasis; a review article
Zarrin, M., & Mahmoudabadi, A. Z. (2009) · Jundishapur Journal of Microbiology · Cited by 33
Risk factors for candidemia in non-neutropenic critical patients in Colombia
Ruiz, G. O., Osorio, J., Valderrama, S., Álvarez, D., Díaz, R. E., Calderón‐Parra, J., Ballesteros, D. A., & Franco, A. (2016) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2015.08.005 · Cited by 33
Fesharaki, S. H., Âghili, S. R., Shokohi, T., & Boroumand, M. A. (2018) · Current Medical Mycology · doi:10.18502/cmm.4.2.63 · Cited by 33
Mímica, L. M. J., Ueda, S. M. Y., Martino, M. D. V., Navarini, A., & Martini, I. J. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000100005 · Cited by 33
Short-course therapy for bloodstream infections in immunocompetent adults
Corey, G. R., Stryjewski, M. E., & Everts, R. J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70567-9 · Cited by 33
Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases
Cornely, O. A., Pappas, P. G., Young, J. H., Maddison, P., & Ullmann, A. J. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.557062 · Cited by 33
The non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole.
Li, L., An, M., Shen, H., Huang, X., Yao, X., Liu, J., Zhu, F., Zhang, S., Chen, S., He, L., et al. (2015) · PubMed · Cited by 33
Candida in the peritoneum: Passenger or pathogen?*
Rex, J. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202129.19154.64 · Cited by 33
Alp, S., Arikan‐Akdagli, S., Gulmez, D., Ascioglu, S., Uzun, O., & Akova, M. (2015) · Mycoses · doi:10.1111/myc.12349 · Cited by 32
Mourer, T., Ghalid, M. E., Pehau‐Arnaudet, G., Kauffmann, B., Loquet, A., Brûlé, S., Cabral, V., d’Enfert, C., & Bachellier‐Bassi, S. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00371-x · Cited by 32
Neoh, C. F., Slavin, M. A., Chen, S. C. ‐., Stewart, K., & Kong, D. C. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.010 · Cited by 32
Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis
Sutar, Y. B., Nabeela, S., Singh, S., Alqarihi, A., Solis, N. V., Ghebremariam, T., Filler, S. G., Ibrahim, A. S., Date, A. A., & Uppuluri, P. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001762 · Cited by 32
Yang, H., Han, S., Zhao, D., & Wang, G. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.054 · Cited by 32
Eggimann, P., Calandra, T., Flückiger, U. M., Billé, J., Garbino, J., Glauser, M., Marchetti, O., Ruef, C., Täuber, M. G., Pittet, D., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2809-8 · Cited by 32
Santis, V. D., Gresoiu, M., Corona, A., Wilson, A. P. R., & Singer, M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku338 · Cited by 32
Genetic determinants of virulence – Candida parapsilosis
Singaravelu, K., Gácser, A., & Nosanchuk, J. D. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.09.018 · Cited by 32
Our 2014 approach to candidaemia
Koehler, P. A., Tacke, D., & Cornely, O. A. (2014) · Mycoses · doi:10.1111/myc.12207 · Cited by 32
Escherichia coli and TNF-α Modulate Macrophage Phagocytosis of Candida glabrata
Hess, D. J., Henry‐Stanley, M. J., Bendel, C. M., Zhang, B., Johnson, M.-A., & Wells, C. L. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.07.022 · Cited by 32
Piqueras, A., Ganapathi, L., Carpenter, J. F., Rubio, T. T., Sandora, T. J., Flett, K. B., & Köhler, J. R. (2021) · Journal of Fungi · doi:10.3390/jof7020078 · Cited by 33
Syscan3, a Kit for Detection of Anti- Candida Antibodies for Diagnosis of Invasive Candidiasis
Philip, A., Odabaşı, Z., Matiuzzi, G., Paetznick, V. L., Tan, S.-W., Warmington, J. R., Rex, J. H., & Ostrosky-Zeichner, L. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4834-4835.2005 · Cited by 32
Pasqualotto, A. C., & Denning, D. W. (2005) · European Oncology & Haematology · doi:10.17925/eoh.2005.0.0.1p · Cited by 32
Chamilos, G., & Kontoyiannis, D. P. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000235166.16421.e5 · Cited by 32
Avances y limitaciones del diagnóstico precoz de las infecciones invasoras causadas por levaduras
Pontón, J., & del Palacio, A. (2007) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(07)70041-4 · Cited by 32
Spanakis, E. K., Kourkoumpetis, T. K., Livanis, G., Peleg, A. Y., & Mylonakis, E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0447 · Cited by 31
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 31
Invasive candidiasis: future directions in non-culture based diagnosis
Posch, W., Heimdörfer, D., Wilflingseder, D., & Lass‐Flörl, C. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1370373 · Cited by 31
Keane, S., Geoghegan, P., Póvoa, P. M. S. R., Nseir, S., Rodríguez, A. H., & Martín‐Loeches, I. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1528872 · Cited by 31
Vannini, M., Emery, S., Lieutier-Colas, F., Legueult, K., Mondain, V., Retur, N., Gastaud, L., Pomares-Estran, C., & Hasseine, L. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101210 · Cited by 31
Lin, L., Wang, M., Zeng, J., Mao, Y., Qin, R., Deng, J., Ouyang, X., Hou, X., Sun, C., Wang, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202206713 · Cited by 31
Hu, B., Du, Z., Kang, Y., Zang, B., Cui, W., Qin, B., Fang, Q., Qiu, H., & Li, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0594-0 · Cited by 31
Han, S., Yim, J., Yoo, C., Kim, Y. W., Han, S. K., Shim, Y.-S., & Lee, S. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.5.671 · Cited by 31
Vigouroux, S., Morin, O., Moreau, P., Harousseau, J., & Milpied, N. J. (2006) · PubMed · Cited by 31
Minea, B., Năstasă, V., Moraru, R., Kolecka, A., Flonta, M., Marincu, I., Man, A., Toma, F., Lupșe, M. S., Doroftei, B., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2240-6 · Cited by 30
Yang, Z., Wang, Q., Ma, K., Shi, P., Liu, W., & Huang, Z. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.12.011 · Cited by 30
Ardehali, S. H., Azimi, T., Fallah, F., Aghamohammadi, N., Alimehr, S., Karimi, A. M., & Azimi, L. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.4.3 · Cited by 30
Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species
Wadhwa, R., Pandey, P., Gupta, G., Aggarwal, T., Kumar, N., Mehta, M., Satija, S., Gulati, M., Madan, J., Dureja, H., et al. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191026105308 · Cited by 30
Fungal Infections in COVID-19 Intensive Care Patients
Coşkun, A. S., & DURMAZ, Ş. Ö. (2021) · Polish Journal of Microbiology · doi:10.33073/pjm-2021-039 · Cited by 30
Luo, S., Hipler, U., Münzberg, C., Skerka, C., & Zipfel, P. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0113192 · Cited by 30
Épidémiologie des candidémies : étude observationnelle prospective d’un an dans l’Ouest de la France
Talarmin, J. P., Boutoille, D., Tattevin, P., Dargère, S., Weinbreck, P., Ansart, S., Chennebault, J. M., Hutin, P., Leautez-Nainville, S., Gay‐Andrieu, F., et al. (2009) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2009.02.008 · Cited by 30
Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
Africa, C. W. J., & Abrantes, P. M. D. S. (2017) · F1000Research · doi:10.12688/f1000research.10327.2 · Cited by 30
Ahmadi, N., Ahmadi, A. N., Kheirali, E., Yadegari, M. H., Bayat, M., Shajiei, A., Amini, A. A., Ashrafi, S., Abolhassani, M., Faezi, S., et al. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.10.006 · Cited by 30
Dysregulation of Ion Homeostasis by Antifungal Agents
Zhang, Y., Muend, S., & Rao, R. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00133 · Cited by 30
Pierce, C. G., Saville, S. P., & Lopez-Ribot, J. L. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12161 · Cited by 30
Tam, J. M., Castro, C. E., Heath, R. J. W., Cardenas, M., Xavier, R. J., Lang, M. J., & Vyas, J. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015215 · Cited by 30
Infection Control Epidemiology and Clinical Microbiology
Diekema, D. J., & Pfaller, M. A. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch6 · Cited by 30
Self-citationProphylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?*
Ostrosky-Zeichner, L. L. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000148226.95597.7e · Cited by 30
Wakieć, R., Gabriel, I., Prasad, R., Becker, J. M., Payne, J. W., & Milewski, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01648-07 · Cited by 29
Factores de riesgo asociados a candidemia en pacientes críticos no neutropénicos en Colombia
Ortíz, G., Osorio, J., Valderrama, S., Álvarez, D., Díaz, R. E., Calderón, J., Ballesteros, D. A., & Franco, A. (2015) · Medicina Intensiva · doi:10.1016/j.medin.2015.08.001 · Cited by 29
ECMM CandiReg—A ready to use platform for outbreaks and epidemiological studies
Koehler, P. A., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Bretagne, S., Klingspor, L., Lagrou, K., Meis, J. F. G. M., Rautemaa‐Richardson, R., Schelenz, S., et al. (2019) · Mycoses · doi:10.1111/myc.12963 · Cited by 29
Yáñez-Carrillo, P., Orta‐Zavalza, E., Gutiérrez‐Escobedo, G., Patrón‐Soberano, A., Peñas, A. D. L., & Castaño, I. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.04.020 · Cited by 29
Candida antifungal drug resistance in sub-Saharan African populations: A systematic review
Africa, C. W. J., & Abrantes, P. M. D. S. (2016) · F1000Research · doi:10.12688/f1000research.10327.1 · Cited by 29
Potential of Anti- Candida Antibodies in Immunoprophylaxis
Cabezas, J., Albaina, O., Montañez, D., Sevilla, M. J., Moragues, M. D., & Pontón, J. (2010) · Immunotherapy · doi:10.2217/imt.09.76 · Cited by 29
Arora, P., Dilbaghi, N., & Chaudhury, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1275-1 · Cited by 29
Genomics and the development of new diagnostics and anti-Candida drugs
Weig, M., & Brown, A. J. P. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.05.007 · Cited by 29
Prevalent nosocomial clusters among causative agents for candidemia in Hamilton, Canada
Maganti, H. B., Yamamura, D. L. R., & Xu, J. (2011) · Medical Mycology · doi:10.3109/13693786.2010.547880 · Cited by 28
An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model
de Freitas, C. G., Lima, S. M. D. F., Freire, M. S., Cantuária, A. P. D. C., Oliveira-Júnior, N. G., dos Santos, T. S., Folha, J. D. S., Ribeiro, S. M., Dias, S. C., Rezende, T. M. B., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02518-16 · Cited by 28
Barchiesi, A., Bazzani, V., Jabczynska, A., Borowski, L. S., Oeljeklaus, S., Warscheid, B., Chacińska, A., Szczęsny, R. J., & Vascotto, C. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167125 · Cited by 28
Associated clinical characteristics of patients with candidemia among different Candida species
Chen, L.-Y., Kuo, S., Wu, H.-S., Yang, S.-P., Chan, Y., Chen, L., & Wang, F. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.001 · Cited by 28
Evolving role of early antifungals in the adult intensive care unit
Lam, S. W., Eschenauer, G. A., & Carver, P. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819dec9b · Cited by 28
Determination of mRNA half-lives inCandida albicansusing thiolutin as a transcription inhibitor
Kebaara, B. W., Nielsen, L. E., Nickerson, K. W., & Atkin, A. L. (2006) · Genome · doi:10.1139/g06-046 · Cited by 28
Candidemia in the in-patient setting: treatment options and economics
Gagne, J. J., & Goldfarb, N. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1643 · Cited by 28
Doxorubicin induces drug efflux pumps inCandida albicans
Kofla, G., Turner, V., Schulz, B., Storch, U., Froelich, D., Rognon, B., Coste, A. T., Sanglard, D., & Ruhnke, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.512022 · Cited by 28
Contemporary Strategies in the Prevention and Management of Fungal Infections
Koehler, P. A., & Cornely, O. A. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.003 · Cited by 28
The Role of Autophagy-Related Proteins in Candida albicans Infections
Tam, J. M., Mansour, M. K., Acharya, M., Sokolovska, A., Timmons, A. K., Lacy‐Hulbert, A., & Vyas, J. M. (2016) · Pathogens · doi:10.3390/pathogens5020034 · Cited by 28
Maurel, V., Denis, B., Camby, M., Jeanne, M., Cornesse, A., Glavnik, B., Alanio, A., Rousseau, A., Lefloch, R., Lagrange-Xélot, M., et al. (2020) · Mycoses · doi:10.1111/myc.13068 · Cited by 28
Lavigne, L. M., O’Brien, X. M., Kim, M., Janowski, J. W., Albina, J. E., & Reichner, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7276 · Cited by 28
Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit
Faiz, S. A., Neale, B. W., Ríos, E. V., Campos, T., Parsley, E., Patel, B., & Ostrosky-Zeichner, L. L. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0666-4 · Cited by 28
Phenotypic and genotypic characterization of Candida species isolated from candideamia in Iran
Sadrossadati, S., Ghahri, M., Fooladi, A. A. I., Sayyahfar, S., Beyraghi, S., & Baseri, Z. (2018) · Current Medical Mycology · doi:10.18502/cmm.4.2.64 · Cited by 27
Su, S., Yan, H., Li, M., Wang, H., Chen, X., Shi, J., & Sun, S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1941868 · Cited by 27
Neves, A., Cartágenes-Pinto, A. C., Rocha, D. A. S., de Sá, L. F. R., Junqueira, M. D. L., & Ferreira‐Pereira, A. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140717 · Cited by 27
Is double coverage of gram-negative organisms necessary?
Johnson, S. J., Ernst, E. J., & Moores, K. G. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090360 · Cited by 27
Gómez, N. S., Torres, R. G., & López, C. C. O. (2017) · Nanotechnology Science and Applications · doi:10.2147/nsa.s96018 · Cited by 27
Hirano, R., Sakamoto, Y., Kitazawa, J., Yamamoto, S., & Kayaba, H. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s156633 · Cited by 27
Shi, H., Dong, S., Zhang, X., Chen, X., Gao, X., & Wang, L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.011 · Cited by 27
Vakil, R., Knilans, K. J., Andes, D. R., & Kwon, G. S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9588-1 · Cited by 27
Ásmundsdóttir, L. R., Erlendsdóttir, H., & Gottfreðsson, M. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510026814 · Cited by 27
Cornely, O. A., Marty, F. M., Stucker, F., Pappas, P. G., & Ullmann, A. J. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02045.x · Cited by 26
The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia
Sobel, J. D. (2007) · Current Fungal Infection Reports · doi:10.1007/s12281-007-0007-6 · Cited by 26
Reboli, A. C., Rotstein, C., Kett, D. H., Maschio, M., Cartier, S., Chambers, R. B., & Tarallo, M. (2011) · PharmacoEconomics · doi:10.2165/11584810-000000000-00000 · Cited by 26
Candidaemia in the non-neutropenic patient: A critique of the guidelines
Deshpande, A., Gaur, S., & Bal, A. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.005 · Cited by 26
Deorukhkar, S. C., & Saini, S. (2012) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/39 · Cited by 26
Pammi, M., Eddama, O., & Weisman, L. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006068.pub3 · Cited by 26
Dalle, F., Lafon, I., L’Ollivier, C., Ferrant, E., Sicard, P., Labruère, C., Jébrane, A., Laubriet, A., Vagner, O., Caillot, D., et al. (2008) · Haematologica · doi:10.3324/haematol.11882 · Cited by 26
Farkas, A., Daróczi, G., Villasurda, P., Dolton, M. J., Nakagaki, M., & Roberts, J. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00970-16 · Cited by 26
Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study
Barber, K. E., Wagner, J. L., Miller, J. M., Lewis, E., & Stover, K. R. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00285-7 · Cited by 26
Incidencia y prevalencia de candidemia en pacientes críticamente enfermos en Colombia
Cortés, J. A., Jaimes, J. A., & Leal, A. L. (2013) · Revista chilena de infectología · doi:10.4067/s0716-10182013000600004 · Cited by 26
Liu, J., Bolstad, D. B., Smith, A. E., Priestley, N. D., Wright, D. L., & Anderson, A. C. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00745.x · Cited by 26
Pappas, P. G., Kauffman, C. A., Andes, D. R., Benjamin, D. K., Calandra, T., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B. J., Ostrosky-Zeichner, L. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598961 · Cited by 26
Díez, A., Carrano, G., Bregón-Villahoz, M., Cuétara, M. S., García‐Ruiz, J. C., Fernandez-de-Larrinoa, Í., & Moragues, M. D. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115509 · Cited by 25
Bravo-Chaucanés, C. P., Vargas‐Casanova, Y., Chitiva, L. C., Ceballos-Garzón, A., Costa, G. M., & Parra‐Giraldo, C. M. (2022) · Journal of Fungi · doi:10.3390/jof8080784 · Cited by 25
Prevention of Health Care-Associated Infections
Diekema, D. J., & Pfaller, M. A. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch8 · Cited by 25
Self-citationAnidulafungin for the treatment of invasive candidiasis
Mayr, A., Aigner, M., & Lass‐Flörl, C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03448.x · Cited by 25
An outbreak of Candida spp. bloodstream infection in a tertiary care center in Bogotá, Colombia
DiazGranados, C. A., Martinez, A., Deaza, C., & Valderrama, S. (2008) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702008000500009 · Cited by 25
Horn, D., Neofytos, D., Fishman, J. A., Steinbach, W. J., Anaissie, E. J., Marr, K. A., Pfaller, M. A., & Olyaei, A. J. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0383-4 · Cited by 25
Self-citationThe epidemiology of fungal infections
Lockhart, S. R., Diekema, D. J., & Pfaller, M. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00001-3 · Cited by 25
Self-citationRisk factors for early invasive fungal disease in critically ill patients
Pitoyo, C. W., Aditianingsih, D., & Rumende, C. M. (2016) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.194007 · Cited by 26
Moreno-García, E., Puerta‐Alcalde, P., Gariup, G., Fernández‐Ruiz, M., López-Cortés, L. E., Cuervo, G., Salavert, M., Merino, P., Machado, M., Guinea, J., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab250 · Cited by 25
Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients
Glöckner, A., & Karthaus, M. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01885.x · Cited by 25
Pratikaki, M. E., Platsouka, E. D., Sotiropoulou, C., Douka, E., Paramythiotou, E., Kaltsas, P., Kotanidou, A. N., Paniara, O., Roussos, C., & Routsi, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01787.x · Cited by 25
Chaves, G. M., Santos, F. P., & Colombo, A. L. (2012) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762012000200008 · Cited by 25
Metadata
- Authors
- Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D.
- Affiliations
- University of Iowa Hospitals and Clinics (US)
- University of Iowa (US)
- Corresponding author
- Diekema, D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1172-1177
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2118236446
- Cited by
- 1,140
- References
- 37
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 22 · 2023: 30 · 2022: 35 · 2021: 34 · 2020: 35 · 2019: 38 · 2018: 35 · 2017: 51 · 2016: 41 · 2015: 59 · 2014: 74 · 2013: 76 · 2012: 60
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial candidemia, attributable mortality, candidemia, mortality, matched case-control comparison, underlying disease, risk factors, nosocomial infections
- MeSH terms
- Age Factors, Antifungal Agents, Candida, Candidiasis, Cross Infection, Female, Humans, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Sex Factors, Cohort Studies, Fluconazole, Survival Rate, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.